Cara Therapeutics Inc (CARA)
0.775
-0.03
(-3.75%)
USD |
NASDAQ |
May 17, 14:53
Cara Therapeutics Total Liabilities (Quarterly): 60.30M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 60.30M |
| December 31, 2023 | 68.76M |
| September 30, 2023 | 29.70M |
| June 30, 2023 | 25.46M |
| March 31, 2023 | 16.68M |
| December 31, 2022 | 23.46M |
| September 30, 2022 | 28.69M |
| June 30, 2022 | 22.15M |
| March 31, 2022 | 19.75M |
| December 31, 2021 | 19.53M |
| September 30, 2021 | 17.90M |
| June 30, 2021 | 17.99M |
| March 31, 2021 | 19.77M |
| December 31, 2020 | 22.16M |
| September 30, 2020 | 19.29M |
| June 30, 2020 | 27.68M |
| March 31, 2020 | 35.70M |
| December 31, 2019 | 46.25M |
| September 30, 2019 | 51.90M |
| June 30, 2019 | 50.10M |
| March 31, 2019 | 56.06M |
| December 31, 2018 | 57.19M |
| Date | Value |
|---|---|
| September 30, 2018 | 63.17M |
| June 30, 2018 | 66.82M |
| March 31, 2018 | 8.532M |
| December 31, 2017 | 10.22M |
| September 30, 2017 | 8.973M |
| June 30, 2017 | 8.753M |
| March 31, 2017 | 14.03M |
| December 31, 2016 | 13.10M |
| September 30, 2016 | 8.35M |
| June 30, 2016 | 9.457M |
| March 31, 2016 | 7.086M |
| December 31, 2015 | 5.853M |
| September 30, 2015 | 4.034M |
| June 30, 2015 | 3.971M |
| March 31, 2015 | 4.23M |
| December 31, 2014 | 4.272M |
| September 30, 2014 | 7.037M |
| June 30, 2014 | 6.626M |
| March 31, 2014 | 6.827M |
| December 31, 2013 | 6.572M |
| September 30, 2013 | 8.477M |
| December 31, 2012 | 3.098M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
16.68M
Minimum
Mar 2023
68.76M
Maximum
Dec 2023
31.16M
Average
24.46M
Median
Total Liabilities (Quarterly) Benchmarks
| Nektar Therapeutics | 269.31M |
| Stereotaxis Inc | 19.42M |
| Cerus Corp | 138.97M |
| Avid Bioservices Inc | 275.06M |
| Rigel Pharmaceuticals Inc | 158.19M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 90.10M |
| Shareholders Equity (Quarterly) | 29.80M |
| Current Ratio | 5.381 |